Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HealthLynked (HLYK) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for HealthLynked (HLYK) over the last 10 years, with Q3 2025 value amounting to $397240.0.

  • HealthLynked's Other Operating Expenses fell 7520.31% to $397240.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year decrease of 4882.4%. This contributed to the annual value of $4.5 million for FY2024, which is 2603.06% down from last year.
  • According to the latest figures from Q3 2025, HealthLynked's Other Operating Expenses is $397240.0, which was down 7520.31% from $548752.0 recorded in Q2 2025.
  • In the past 5 years, HealthLynked's Other Operating Expenses ranged from a high of $18.8 million in Q4 2021 and a low of -$1.5 million during Q4 2022
  • Over the past 5 years, HealthLynked's median Other Operating Expenses value was $793069.0 (recorded in 2024), while the average stood at $1.7 million.
  • Within the past 5 years, the most significant YoY rise in HealthLynked's Other Operating Expenses was 5421712.31% (2023), while the steepest drop was 12797.38% (2023).
  • HealthLynked's Other Operating Expenses (Quarter) stood at $18.8 million in 2021, then plummeted by 107.84% to -$1.5 million in 2022, then soared by 174.14% to $1.1 million in 2023, then fell by 27.5% to $793069.0 in 2024, then tumbled by 49.91% to $397240.0 in 2025.
  • Its Other Operating Expenses was $397240.0 in Q3 2025, compared to $548752.0 in Q2 2025 and $734158.0 in Q1 2025.